Biocom Announces the 11th Annual Life Science Catalyst Award Winners
13 Life Science Trailblazers Under the Age of 40 Recognized Across California
SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, October 26, 2026--Biocom, the world's largest life science association, today announced the winners of its 11th annual Life Science Catalyst Awards. The awards recognize rising and accomplished leaders who are making significant contributions to the life science industry in California before reaching their 40th birthday.
"As we celebrate the 11th year of the Catalyst Awards, we are proud to recognize 13 leaders who represent the depth, diversity and ambition of California's life science ecosystem," said Tim Scott, president and CEO of Biocom. "This year's honorees are turning bold ideas into meaningful progress, from personalized cancer vaccines and functional genomics to drug discovery, regenerative agriculture and biotechnology commercialization. They are advancing science, building companies, mentoring the next generation and creating partnerships that move innovation forward. We are proud to celebrate their achievements and the impact they are already making across the state and beyond."
Biocom selected the 13 winners from an outstanding pool of over 100 nominees across biotechnology, pharmaceuticals, diagnostics, medical technology, venture funding, industrial biotechnology and service providers. A statewide panel of industry experts and past winners evaluated nominees based on their impact on their company, the community and the industry, as well as their leadership, innovation and accomplishments.
In alphabetical order, the 2026 Life Science Catalyst Award winners are:
Ioana Aanei, Ph.D. – director, business development and alliance management, Scribe Therapeutics
Sarah Allard, Ph.D. – executive director, University of California, San Diego Soil Health Center
Aarash Bordbar, Ph.D. – co-founder, CEO, CSO and board member, Sinopia Biosciences
Anastasia Budinskaya, M.S. – principal, NFX
Kevin Caldwell, J.D. – co-founder, president and CEO, Ossium Health
David de Vries, M.Phil. – co-founder and CEO, Tr1X
Christopher Farina, M.S., RAC – CEO, Abcentra
Evan Feinberg, Ph.D. – founder and CEO, Genesis Molecular AI
Guosong Hong, Ph.D. – associate professor of materials science and engineering, Stanford University
Abubakar Jalloh, Ph.D. – site head, BioLabs San Diego
Xin Jin, Ph.D. – associate professor of neuroscience, Scripps Research and co-founder, PerturbAI
Lada Nuzhna, M.S. – CEO, General Control
Timothy Sears, Ph.D. – co-founder and CEO, Invoke Bio